September 2026 — what changed

State Street® SPDR® S&P® U.S. Health Care Select Sector UCITS ETF (Acc) · IE00BWBXM617 · SXLV · snapshots compared: 19 Aug → 31 August 2026

In brief: 0 holdings added and 0 removed from the basket · 1 weight change beyond ±0.25 points · monthly return +4.9% · costs and key facts unchanged.

Basket — holdings added (0)

None.

Basket — holdings removed (0)

None.

Holdings compared (excluding cash instruments): 60 → 60.

Holding weights

Holding	from	to
Eli Lilly and Company	15.86%	14.85%

Top 10 — before and after

Holding	5 Aug	31 Aug
Eli Lilly and Company	15.91%	14.85%
Johnson & Johnson	10.44%	10.57%
AbbVie Inc.	7.27%	7.44%
Merck & Co. Inc.	5.35%	5.99%
UnitedHealth Group Incorporated	6.19%	5.83%
Amgen Inc.	3.69%	3.83%
Thermo Fisher Scientific Inc.	3.64%	3.61%
Abbott Laboratories	3.17%	3.07%
Gilead Sciences Inc.	2.74%	3.01%
Pfizer Inc.	2.52%	2.63%

Combined top-10 weight: 60.9% → 60.8%.

Sectors — where the weight moved

Health Care

100.0 → 100.0

Bars scaled to the change: orange = up, grey = down. Basket percentages at the two snapshots.

Countries

Country	5 Aug	31 Aug
United States	100.0%	100.0%

Nearly unchanged: beyond the largest countries, every move stays within ±0.2 points.

Monthly return

+4.9% in USD (NAV 50.55 → 53, 31 Jul → 31 Aug). Accumulating fund: no distributions.

Assets over the month

550 mln $ → 554 mln $ (issuer’s daily series).

Costs and key facts

TER	0.15% — unchanged
Transaction costs (KID)	0.00% — unchanged
Index, name, policy	no change in the period

Issuer-declared basket snapshots, compared by Rebalix. Each section states its own dates: the basket comparison uses the issuer file dates; top 10 and breakdowns the dates of the two archived snapshots. Weight changes are shown above ±0.25 points (the archive records them from ±0.1). We record the past: nothing on this page is a recommendation.